Translational research

Translational research projects encourage collaborations between basic and clinical research. Their goal is to study cells and their interactions with the environment, and in so doing to provide new impulses for novel therapies and clinical approaches in order to be able to act on the causes of cellular malfunction.  

Financial support for translational cancer research projects is possible thanks to:

"Allocated funds" - These funds are specifically created for each project. They come from private donations and must be used for the predetermined purpose. The Foundation guarantees that donations are used in full to finance the project to which they have been allocated.

“ISREC chairs” - These are created to offer young professors affiliated to the EPFL (School of Life Sciences - ISREC) or to a Swiss University (Faculty of biology or medicine) the opportunity to launch their career in research. They are financed by the fortune of the Foundation.

Translational research - ongoing projects

Developing off-the-shelf allogeneic chimeric antigen receptor T cells for childhood leukemia

This “allocated fund” derived from a donation of the Empiris charitable umbrella foundation was granted to Prof. Caroline Arber (CHUV) in April 2022…

More information

Targeting novel molecular networks underlying bladder cancer recurrence and progression

This “allocated fund” was granted to Prof. Camilla Jandus (University of Geneva) and Prof. Grégory Verdeil (University of Lausanne) in April 2022 for…

More information

Understanding how clonal hematopoiesis feeds lymphoma

This “allocated fund” was granted to Prof. Davide Rossi (Università della Svizzera italiana - Institute of Oncology Research IOR) in March 2022 for 3…

More information

News & Events

Posted on

Congratulations to Dr. Grégory Verdeil and his team on the publication of an article in the prestigious journal Nature Immunology, in which they were…

Read more
Posted on

Once again, the SUR-SRP “Summer Research” program (July 3 to August 25), organized by the UNIL and the EPFL and supported by the ISREC Foundation, was…

Read more
Posted on

This year, six research groups working in Lausanne, Geneva, Bern and Bellinzona were awarded a TANDEM grant.

Each team, consisting of a clinician and…

Read more
Posted on

Congratulations to Prof. Mikaël Pittet, holder of the ISREC Foundation’s Immuno-Oncology Chair at the University of Geneva: in an article published in…

Read more